IBM and Pfizer claim to have developed a model that can predict the onset of Alzheimer’s disease years before clear symptoms develop.
On Friday, the pharmaceutical company Biogen announced the Food and Drug Administration accepted its application to conduct a priority review of their experimental Alzheimer’s drug for approval. The speedier-than-usual process sets the stage for the tr…
Baby boomers are experiencing a sharper drop in cognitive function as they age, relative to previous generations. The findings not only suggest that boomers will be more likely to develop conditions like dementia than past cohorts, but future aging gen…
Shares of Swiss biopharma AC Immune SA (NASDAQ: ACIU) were advancing strongly Thursday following a clinical trial update from the company.
Cassava Sciences Inc (NASDAQ: SAVA) shares have tumbled to their lowest level since mid-December 2019 after the company issued an adverse clinical readout.